Synthetic Biologics Inc. announced Maureen Early joined the team in the newly created position of Vice President, Commercial. In her new role, Ms. Early will lead all commercial and marketing efforts for the company's current and future product portfolio. Ms. Early was President and Co-founder of Upside Endeavors.

Ms. Early was President and Co-founder of Upside Endeavors. She was responsible for business development, project execution, daily operations and was heavily involved in the launch and lifecycle planning of many products, including Prevnar 13® for adults and pediatrics, Relistor®, Tygacil®, Zyvox®, Remicade®, Stelara®, Zytiga® and Erbitux®.